Clinical Trial Update: Interventional Treatment of Residual Pulmonary Hypertension in Patients After Pulmonary Thromboendarterectomy [Phase 2]

View source ↗

Summary

Phase 2 interventional trial update for residual pulmonary hypertension after pulmonary thromboendarterectomy; trial status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thromboembolic Pulmonary Hypertension

Snippet

Sponsor: Novosibirsk Scientific Research Institute for Circulatory Pathology | Conditions: Chronic Thromboembolic Pulmonary Hypertension | Phase 2 | Status: UNKNOWN